Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry
CONCLUSIONS: ViV TAVI using either ACURATE or Evolut THVs showed similar procedural outcomes. However, a true ID >19 mm was associated with higher device success among ACURATE recipients, whereas in patients with a true ID ≤19 mm, device success was higher when using Evolut.PMID:38506737 | PMC:PMC10941672 | DOI:10.4244/EIJ-D-23-00779 (Source: EuroIntervention)
Source: EuroIntervention - March 20, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Won-Keun Kim Moritz Seiffert Andreas R ück David M Leistner Henryk Dreger Hendrik Wienemann Matti Adam Helge M öllmann Johannes Blumenstein Clemens Eckel Andrea Buono Diego Maffeo Antonio Messina Andreas Holzamer Samuel Sossalla Giuliano Costa Marco Bar Source Type: research
Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure
CONCLUSIONS: Redo-TAVI with an ACn2/AC XL within an S3 has favourable hydrodynamic performance and less pinwheeling compared to an S3 in S3. This comes at the price of a taller neoskirt.PMID:38506739 | PMC:PMC10941669 | DOI:10.4244/EIJ-D-23-00783 (Source: EuroIntervention)
Source: EuroIntervention - March 20, 2024 Category: Cardiovascular & Thoracic Surgery Authors: David Meier Daire Grant Chris Frawley Mariama Akodad Uri Landes Arif A Kokhar Dariusz Dudek Isaac George Michael J Rinaldi Won-Keun Kim Steven J Yakubov Paul Sorajja Giuseppe Tarantini David A Wood John G Webb Stephanie L Sellers Janarthanan Sathananthan Source Type: research
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry
CONCLUSIONS: ViV TAVI using either ACURATE or Evolut THVs showed similar procedural outcomes. However, a true ID >19 mm was associated with higher device success among ACURATE recipients, whereas in patients with a true ID ≤19 mm, device success was higher when using Evolut.PMID:38506737 | PMC:PMC10941672 | DOI:10.4244/EIJ-D-23-00779 (Source: EuroIntervention)
Source: EuroIntervention - March 20, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Won-Keun Kim Moritz Seiffert Andreas R ück David M Leistner Henryk Dreger Hendrik Wienemann Matti Adam Helge M öllmann Johannes Blumenstein Clemens Eckel Andrea Buono Diego Maffeo Antonio Messina Andreas Holzamer Samuel Sossalla Giuliano Costa Marco Bar Source Type: research
Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure
CONCLUSIONS: Redo-TAVI with an ACn2/AC XL within an S3 has favourable hydrodynamic performance and less pinwheeling compared to an S3 in S3. This comes at the price of a taller neoskirt.PMID:38506739 | PMC:PMC10941669 | DOI:10.4244/EIJ-D-23-00783 (Source: EuroIntervention)
Source: EuroIntervention - March 20, 2024 Category: Cardiovascular & Thoracic Surgery Authors: David Meier Daire Grant Chris Frawley Mariama Akodad Uri Landes Arif A Khokhar Dariusz Dudek Isaac George Michael J Rinaldi Won-Keun Kim Steven J Yakubov Paul Sorajja Giuseppe Tarantini David A Wood John G Webb Stephanie L Sellers Janarthanan Sathananthan Source Type: research
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry
CONCLUSIONS: ViV TAVI using either ACURATE or Evolut THVs showed similar procedural outcomes. However, a true ID >19 mm was associated with higher device success among ACURATE recipients, whereas in patients with a true ID ≤19 mm, device success was higher when using Evolut.PMID:38506737 | PMC:PMC10941672 | DOI:10.4244/EIJ-D-23-00779 (Source: EuroIntervention)
Source: EuroIntervention - March 20, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Won-Keun Kim Moritz Seiffert Andreas R ück David M Leistner Henryk Dreger Hendrik Wienemann Matti Adam Helge M öllmann Johannes Blumenstein Clemens Eckel Andrea Buono Diego Maffeo Antonio Messina Andreas Holzamer Samuel Sossalla Giuliano Costa Marco Bar Source Type: research
Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure
CONCLUSIONS: Redo-TAVI with an ACn2/AC XL within an S3 has favourable hydrodynamic performance and less pinwheeling compared to an S3 in S3. This comes at the price of a taller neoskirt.PMID:38506739 | PMC:PMC10941669 | DOI:10.4244/EIJ-D-23-00783 (Source: EuroIntervention)
Source: EuroIntervention - March 20, 2024 Category: Cardiovascular & Thoracic Surgery Authors: David Meier Daire Grant Chris Frawley Mariama Akodad Uri Landes Arif A Khokhar Dariusz Dudek Isaac George Michael J Rinaldi Won-Keun Kim Steven J Yakubov Paul Sorajja Giuseppe Tarantini David A Wood John G Webb Stephanie L Sellers Janarthanan Sathananthan Source Type: research
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry
CONCLUSIONS: ViV TAVI using either ACURATE or Evolut THVs showed similar procedural outcomes. However, a true ID >19 mm was associated with higher device success among ACURATE recipients, whereas in patients with a true ID ≤19 mm, device success was higher when using Evolut.PMID:38506737 | PMC:PMC10941672 | DOI:10.4244/EIJ-D-23-00779 (Source: EuroIntervention)
Source: EuroIntervention - March 20, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Won-Keun Kim Moritz Seiffert Andreas R ück David M Leistner Henryk Dreger Hendrik Wienemann Matti Adam Helge M öllmann Johannes Blumenstein Clemens Eckel Andrea Buono Diego Maffeo Antonio Messina Andreas Holzamer Samuel Sossalla Giuliano Costa Marco Bar Source Type: research
Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure
CONCLUSIONS: Redo-TAVI with an ACn2/AC XL within an S3 has favourable hydrodynamic performance and less pinwheeling compared to an S3 in S3. This comes at the price of a taller neoskirt.PMID:38506739 | PMC:PMC10941669 | DOI:10.4244/EIJ-D-23-00783 (Source: EuroIntervention)
Source: EuroIntervention - March 20, 2024 Category: Cardiovascular & Thoracic Surgery Authors: David Meier Daire Grant Chris Frawley Mariama Akodad Uri Landes Arif A Khokhar Dariusz Dudek Isaac George Michael J Rinaldi Won-Keun Kim Steven J Yakubov Paul Sorajja Giuseppe Tarantini David A Wood John G Webb Stephanie L Sellers Janarthanan Sathananthan Source Type: research
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry
CONCLUSIONS: ViV TAVI using either ACURATE or Evolut THVs showed similar procedural outcomes. However, a true ID >19 mm was associated with higher device success among ACURATE recipients, whereas in patients with a true ID ≤19 mm, device success was higher when using Evolut.PMID:38506737 | PMC:PMC10941672 | DOI:10.4244/EIJ-D-23-00779 (Source: EuroIntervention)
Source: EuroIntervention - March 20, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Won-Keun Kim Moritz Seiffert Andreas R ück David M Leistner Henryk Dreger Hendrik Wienemann Matti Adam Helge M öllmann Johannes Blumenstein Clemens Eckel Andrea Buono Diego Maffeo Antonio Messina Andreas Holzamer Samuel Sossalla Giuliano Costa Marco Bar Source Type: research
Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure
CONCLUSIONS: Redo-TAVI with an ACn2/AC XL within an S3 has favourable hydrodynamic performance and less pinwheeling compared to an S3 in S3. This comes at the price of a taller neoskirt.PMID:38506739 | PMC:PMC10941669 | DOI:10.4244/EIJ-D-23-00783 (Source: EuroIntervention)
Source: EuroIntervention - March 20, 2024 Category: Cardiovascular & Thoracic Surgery Authors: David Meier Daire Grant Chris Frawley Mariama Akodad Uri Landes Arif A Khokhar Dariusz Dudek Isaac George Michael J Rinaldi Won-Keun Kim Steven J Yakubov Paul Sorajja Giuseppe Tarantini David A Wood John G Webb Stephanie L Sellers Janarthanan Sathananthan Source Type: research
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry
CONCLUSIONS: ViV TAVI using either ACURATE or Evolut THVs showed similar procedural outcomes. However, a true ID >19 mm was associated with higher device success among ACURATE recipients, whereas in patients with a true ID ≤19 mm, device success was higher when using Evolut.PMID:38506737 | PMC:PMC10941672 | DOI:10.4244/EIJ-D-23-00779 (Source: EuroIntervention)
Source: EuroIntervention - March 20, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Won-Keun Kim Moritz Seiffert Andreas R ück David M Leistner Henryk Dreger Hendrik Wienemann Matti Adam Helge M öllmann Johannes Blumenstein Clemens Eckel Andrea Buono Diego Maffeo Antonio Messina Andreas Holzamer Samuel Sossalla Giuliano Costa Marco Bar Source Type: research
Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure
CONCLUSIONS: Redo-TAVI with an ACn2/AC XL within an S3 has favourable hydrodynamic performance and less pinwheeling compared to an S3 in S3. This comes at the price of a taller neoskirt.PMID:38506739 | PMC:PMC10941669 | DOI:10.4244/EIJ-D-23-00783 (Source: EuroIntervention)
Source: EuroIntervention - March 20, 2024 Category: Cardiovascular & Thoracic Surgery Authors: David Meier Daire Grant Chris Frawley Mariama Akodad Uri Landes Arif A Khokhar Dariusz Dudek Isaac George Michael J Rinaldi Won-Keun Kim Steven J Yakubov Paul Sorajja Giuseppe Tarantini David A Wood John G Webb Stephanie L Sellers Janarthanan Sathananthan Source Type: research
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry
CONCLUSIONS: ViV TAVI using either ACURATE or Evolut THVs showed similar procedural outcomes. However, a true ID >19 mm was associated with higher device success among ACURATE recipients, whereas in patients with a true ID ≤19 mm, device success was higher when using Evolut.PMID:38506737 | PMC:PMC10941672 | DOI:10.4244/EIJ-D-23-00779 (Source: EuroIntervention)
Source: EuroIntervention - March 20, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Won-Keun Kim Moritz Seiffert Andreas R ück David M Leistner Henryk Dreger Hendrik Wienemann Matti Adam Helge M öllmann Johannes Blumenstein Clemens Eckel Andrea Buono Diego Maffeo Antonio Messina Andreas Holzamer Samuel Sossalla Giuliano Costa Marco Bar Source Type: research
Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure
CONCLUSIONS: Redo-TAVI with an ACn2/AC XL within an S3 has favourable hydrodynamic performance and less pinwheeling compared to an S3 in S3. This comes at the price of a taller neoskirt.PMID:38506739 | PMC:PMC10941669 | DOI:10.4244/EIJ-D-23-00783 (Source: EuroIntervention)
Source: EuroIntervention - March 20, 2024 Category: Cardiovascular & Thoracic Surgery Authors: David Meier Daire Grant Chris Frawley Mariama Akodad Uri Landes Arif A Khokhar Dariusz Dudek Isaac George Michael J Rinaldi Won-Keun Kim Steven J Yakubov Paul Sorajja Giuseppe Tarantini David A Wood John G Webb Stephanie L Sellers Janarthanan Sathananthan Source Type: research
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry
CONCLUSIONS: ViV TAVI using either ACURATE or Evolut THVs showed similar procedural outcomes. However, a true ID >19 mm was associated with higher device success among ACURATE recipients, whereas in patients with a true ID ≤19 mm, device success was higher when using Evolut.PMID:38506737 | PMC:PMC10941672 | DOI:10.4244/EIJ-D-23-00779 (Source: EuroIntervention)
Source: EuroIntervention - March 20, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Won-Keun Kim Moritz Seiffert Andreas R ück David M Leistner Henryk Dreger Hendrik Wienemann Matti Adam Helge M öllmann Johannes Blumenstein Clemens Eckel Andrea Buono Diego Maffeo Antonio Messina Andreas Holzamer Samuel Sossalla Giuliano Costa Marco Bar Source Type: research
